First-of-its-kind COVID-19 antibody treatment: FDA authorization requested

November 2, 2021 4:02 pm

It could be the first long-acting antibody combination to receive an emergency authorization in the U.S. for COVID-19 prevention.

Category: News
About The Author
-
Previous

LIVE: FDA advisory panel to vote on J&J Covid booster shots — 10/15/2021
Next

CDC Statement on ACIP Booster Recommendations

Related Videos

FDA authorizes Pfizer’s COVID-19 vaccine boosters l GMA

FDA authorizes Pfizer’s COVID-19 vaccine boosters l GMA

2 FDA Experts Raise Doubts About COVID-19 Booster Shots

2 FDA Experts Raise Doubts About COVID-19 Booster Shots

FDACDC Phase6

Tense decision-making as CDC joins FDA in recommending Pfizer booster shot for 65 & up, people at high risk and those with occupational exposure to COVID-19

FDA Advisory Panel Unanimously Recommends Moderna Booster Shots Against Covid

FDA Advisory Panel Unanimously Recommends Moderna Booster Shots Against Covid

LIVE: FDA advisory panel to vote on J&J Covid booster shots — 10/15/2021

LIVE: FDA advisory panel to vote on J&J Covid booster shots — 10/15/2021

FDA committee meets to debate and vote on Covid booster shots for the general public — 9/17/21

FDA committee meets to debate and vote on Covid booster shots for the general public — 9/17/21